- Home
- ICUI vs LBTYB Comparison
ICUI vs LBTYB Comparison
Compare ICUI & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- LBTYB
- Stock Information
- Founded
- ICUI 1984
- LBTYB 2004
- Country
- ICUI United States
- LBTYB Bermuda
- Employees
- ICUI N/A
- LBTYB N/A
- Industry
- ICUI Medical/Dental Instruments
- LBTYB Cable & Other Pay Television Services
- Sector
- ICUI Health Care
- LBTYB Telecommunications
- Exchange
- ICUI Nasdaq
- LBTYB Nasdaq
- Market Cap
- ICUI 3.4B
- LBTYB 3.7B
- IPO Year
- ICUI 1992
- LBTYB N/A
- Fundamental
- Price
- ICUI $134.86
- LBTYB $9.58
- Analyst Decision
- ICUI Strong Buy
- LBTYB
- Analyst Count
- ICUI 5
- LBTYB 0
- Target Price
- ICUI $196.75
- LBTYB N/A
- AVG Volume (30 Days)
- ICUI 283.6K
- LBTYB 708.0
- Earning Date
- ICUI 05-08-2025
- LBTYB 01-01-0001
- Dividend Yield
- ICUI N/A
- LBTYB N/A
- EPS Growth
- ICUI N/A
- LBTYB N/A
- EPS
- ICUI N/A
- LBTYB N/A
- Revenue
- ICUI $2,420,093,000.00
- LBTYB $4,421,800,000.00
- Revenue This Year
- ICUI N/A
- LBTYB $6.11
- Revenue Next Year
- ICUI N/A
- LBTYB $0.37
- P/E Ratio
- ICUI N/A
- LBTYB N/A
- Revenue Growth
- ICUI 7.22
- LBTYB 32.44
- 52 Week Low
- ICUI $101.44
- LBTYB $9.15
- 52 Week High
- ICUI $196.26
- LBTYB $21.90
- Technical
- Relative Strength Index (RSI)
- ICUI 48.47
- LBTYB 42.26
- Support Level
- ICUI $127.91
- LBTYB $9.35
- Resistance Level
- ICUI $135.62
- LBTYB $9.70
- Average True Range (ATR)
- ICUI 4.35
- LBTYB 0.05
- MACD
- ICUI -0.26
- LBTYB 0.06
- Stochastic Oscillator
- ICUI 33.77
- LBTYB 74.14
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.